Contributors

Dawn Hayward

Dawn Hayward
Dawn Hayward is a communications fellow at the National Cancer Institute. She earned a Ph.D. in biochemistry from the Johns Hopkins University School of Medicine

Articles by Dawn Hayward

From the journals: JLR
Journal News

From the journals: JLR

1/28/2020
Topics include fatty livers and hormones, how pathogens exploit lipid rafts and the lipoprotein–blood clot link.
From the journals: November 2019
Journal News

From the journals: November 2019

11/1/2019
What is mitochondria’s role in non-alcoholic fatty liver disease? What’s the best way to differentiate embryonic and mesenchymal stem cells to use MSCs in therapy? How do fatty acids reduce melanin in tumor cells? Researchers tackle these questions …
From the journals: April 2019
Journal News

From the journals: April 2019

4/1/2019
What structural features of a cortisol-producing enzyme could help in treating Cushing’s disease? Can melatonin be used to treat obesity? How does a gut pathogen evade antibiotic treatment? These and other questions are addressed in our roundup.
Ruma Banerjee honored for discoveries in vitamin B12 and H2S signaling
Award

Ruma Banerjee honored for discoveries in vitamin B12 and H2S signaling

4/1/2019
Ruma Banerjee has unraveled much of the mystery behind the cofactor vitamin B12, including transport to other proteins and the kinetics of a related sulfur signaling pathway.
Bioinorganic chemist Damasceno honored for research on labile iron pool
Award

Bioinorganic chemist Damasceno honored for research on labile iron pool

3/1/2019
A graduate student at the Universidade de Sao Paulo in Brazil wins a JBC/Tabor award for research showing that the labile iron pool can prevent oxidative damage.
From the journals: January 2019
Journal News

From the journals: January 2019

1/1/2019
What’s the link between chronic diabetes and cognitive decline? How does the body protect the liver during periods of fasting? Why do some pain drugs work in rodents but not in people?
From the journals: October 2018
Journal News

From the journals: October 2018

10/1/2018
A gene that can both increase and decrease diabetes risk. A protein that makes tumor cells more aggressive. Citrus compounds that reverse obesity. Read about these topics and more in our roundup of recent papers from the Journal of Biological Che…
Hart honored for glycobiology breakthroughs
Award

Hart honored for glycobiology breakthroughs

4/1/2018
Gerald Hart created an entirely new field” by showing that O-linked beta N-acetylglucosamine, or O-GlcNAc, “occurs in both the nucleus and cytoplasm of mammalian cells.”
Postdoc wins Tabor award for lipid membrane research
Award

Postdoc wins Tabor award for lipid membrane research

1/1/2018
Itay Budin and colleagues at the University of California, Berkeley, used metabolic engineering to determine that a cell’s membrane can act as an environmental sensor.
JBC: Series explores interactions between microbes and the gut
Journal News

JBC: Series explores interactions between microbes and the gut

8/1/2017
Six articles in the Journal of Biological Chemistry explore interactions between metabolites and the human host, including natural products, drug metabolism and the concept of colonization resistance.
JBC: A causal gene for X-linked intellectual disability
Journal News

JBC: A causal gene for X-linked intellectual disability

6/1/2017
A recent study in the Journal of Biological Chemistry reports a new causal gene for X-linked intellectual disability, a heritable condition that primarily affects males.
Taylor honored for work on protein kinase A
Award

Taylor honored for work on protein kinase A

4/1/2017
Susan Taylor at the University of California, San Diego, won the ASBMB's Earl and Thressa Stadtman Award.
Shoichet recognized for informatics tools for drug discovery
Award

Shoichet recognized for informatics tools for drug discovery

4/1/2017
Brian Shoichet at the University of California, San Francisco, wins award for informatics tools for drug discovery.
JLR: Sphingolipids and retinal degeneration
Journal News

JLR: Sphingolipids and retinal degeneration

9/1/2016
A multiple sclerosis drug may be used to treat retinal degeneration.
JLR: Using microRNAs >/br>to target cancer cells
Journal News

JLR: Using microRNAs to target cancer cells

3/1/2016
A recent review in the Journal of Lipid research delves into how microRNAs — small, single-stranded RNA molecules that can stop the synthesis of proteins — can be used to slow and potentially halt the production of cancer cells.